Manipal Health Enterprises Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Future growth expectations for Manipal Health Enterprises Limited: - Continued ramp-up of greenfield hospitals: 3 new facilities in Bengaluru, plus upcoming expansions in Raipur (end of fiscal year), Juhu (Mumbai), and Wakad (Pune). - Bed capacity to increase significantly with over 13,000 beds currently, and additional 1,000+ to 2,000+ beds coming online soon. - Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. - Occupancy improvements (currently ~65%) with headroom to grow further. - Specialty focus on Centres of Excellence with high-acuity specialties contributing 65% of revenue and IP revenues up 45%. - Expansion into oncology and advanced specialty services across key locations. - Leveraging digital revenue streams, which contribute 23% of overall revenue. - Inorganic expansion opportunities considered in Kerala, NCR, and Hyderabad. - Operating efficiencies, improved material costs, reduced length of stay, and conversion efficiencies to drive growth sustainably.

The transcript from Manipal Health Enterprises Limited's August 21, 2026 earnings call does not explicitly mention the current or expected order book or pending orders. However, key growth drivers and capacity expansion plans indicate a strong pipeline of projects and investments: - Multiple greenfield projects commissioned recently in Bengaluru, Raipur (expected end of fiscal), Juhu in Mumbai, and Wakad in Pune upcoming. - Bed capacity expansion of over 1,000 beds planned in FY27, including Nashik (103 beds), Electronic City Bengaluru (~300 beds), Raipur, and additional capacity like Kinder hospital acquisition. - Total capex guidance of around INR4,000 crores over the next 3-4 years for adding 3,000 beds. - Deleveraged balance sheet with net debt to EBITDA at 0.9x post IPO, enabling further inorganic growth including potential expansions in Kerala, NCR, Hyderabad. - Continued focus on ramping up existing commitments; no specific mention of pending orders beyond these planned expansions. Hence, growth visibility is strong based on existing committed bed additions and inorganic opportunities.